Universe Pharmaceuticals Stock Price on December 1, 2023
| UPC Stock | USD 0.64 0 0.47% |
If you're considering investing in Universe Stock, it is important to understand the factors that can impact its price. As of today, the current price of Universe Pharmaceuticals stands at 0.64, as last reported on the 23rd of December, with the highest price reaching 0.64 and the lowest price hitting 0.61 during the day. Universe Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.004, which indicates the firm had a -0.004% return per unit of risk over the last 3 months. Universe Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Universe Pharmaceuticals' Coefficient Of Variation of (6,369), insignificant risk adjusted performance, and Variance of 928.16 to confirm the risk estimate we provide.
The current year's Common Stock Shares Outstanding is expected to grow to about 5.2 M, whereas Total Stockholder Equity is forecasted to decline to about 34.4 M. . As of December 23, 2024, Price To Sales Ratio is expected to decline to 1.75. The current year's Price Earnings Ratio is expected to grow to -9.16. Universe Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Universe |
Sharpe Ratio = -0.004
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UPC |
Estimated Market Risk
| 30.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Universe Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Universe Pharmaceuticals by adding Universe Pharmaceuticals to a well-diversified portfolio.
Price Book 0.0501 | Enterprise Value Ebitda 0.3117 | Price Sales 0.0501 | Shares Float 3.3 M | Earnings Share (76.35) |
Related Headline
Alpha Teknova Headline on 1st of December 2023
Purchase by Ken Gelhaus of 3587 shares of Alpha Teknova by Ken Gelhaus
Filed transaction by Alpha Teknova Inc officer. General open market or private purchase of non-derivative or derivative security
Universe Pharmaceuticals Valuation on December 1, 2023
It is possible to determine the worth of Universe Pharmaceuticals on a given historical date. On December 1, 2023 Universe was worth 12.0 at the beginning of the trading date compared to the closed value of 13.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Universe Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Universe Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Universe Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Universe Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 13.50 | 14.76 | 12.00 | 12.67 | 788.00 | |
12/01/2023 | 12.00 | 14.47 | 12.00 | 13.50 | 1,982 |
| 13.80 | 18.45 | 13.80 | 16.80 | 3,971 |
| Backtest Universe Pharmaceuticals | | | Universe Pharmaceuticals History | | | Universe Pharmaceuticals Valuation | Previous | Next |
Universe Pharmaceuticals Trading Date Momentum on December 1, 2023
| On December 04 2023 Universe Pharmaceuticals was traded for 16.80 at the closing time. Highest Universe Pharmaceuticals's price during the trading hours was 18.45 and the lowest price during the day was 13.80 . The net volume was 4 K. The overall trading history on the 4th of December contributed to the next trading period price growth. The trading price change to the next next day price was 24.44% . The trading price change to current price is 57.78% . |
Universe Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Universe Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Universe Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Universe financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Universe Pharmaceuticals Stock history
Universe Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Universe is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Universe Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Universe Pharmaceuticals stock prices may prove useful in developing a viable investing in Universe Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.3 M | 5.2 M | |
| Net Loss | -7.9 M | -7.5 M |
Universe Pharmaceuticals Quarterly Net Working Capital |
|
Universe Pharmaceuticals Stock Technical Analysis
Universe Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Universe Pharmaceuticals Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Universe Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Universe Pharmaceuticals December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Universe Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Universe Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Universe Pharmaceuticals stock market strength indicators, traders can identify Universe Pharmaceuticals entry and exit signals to maximize returns
Universe Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Universe Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Universe Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Universe to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.34) | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |